Ternary Therapeutics, a biotech startup building an AI platform to create a class of medicines known as “molecular glues”, has secured a £3.6m seed investment. The London-based business was founded in 2024 to develop a platform combining machine learning and physics-based molecular modelling and rapid laboratory testing to design a new class of medicines known […] The post Biotech building ‘molecular glues’ AI platform raises £3.6m appeared first on UKTN .